CN110946937A - Medicament for treating gynecological diseases - Google Patents

Medicament for treating gynecological diseases Download PDF

Info

Publication number
CN110946937A
CN110946937A CN202010003734.0A CN202010003734A CN110946937A CN 110946937 A CN110946937 A CN 110946937A CN 202010003734 A CN202010003734 A CN 202010003734A CN 110946937 A CN110946937 A CN 110946937A
Authority
CN
China
Prior art keywords
medicament
powder
motherwort
fructus
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010003734.0A
Other languages
Chinese (zh)
Inventor
俞东飞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202010003734.0A priority Critical patent/CN110946937A/en
Publication of CN110946937A publication Critical patent/CN110946937A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/234—Cnidium (snowparsley)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489—Sophora, e.g. necklacepod or mamani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/533—Leonurus (motherwort)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/84—Valerianaceae (Valerian family), e.g. valerian
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps

Abstract

The invention relates to the technical field of traditional Chinese medicine treatment, in particular to a medicament for treating gynecological diseases, which has the advantages of good treatment effect, convenient carrying and use, low cost, short treatment course and high cure rate; the powder is powder with the fineness of more than 95 percent of the powder passing through a 75 mu m test sieve, and comprises the following raw materials: placenta hominis, endothelium corneum gigeriae galli, herba patriniae, radix paeoniae rubra, motherwort, dandelion, calcined alum, borneol, radix sophorae flavescentis, fructus cnidii, fructus kochiae, dragon's blood and safflower, wherein the addition amount of each raw material is as follows: 300-400 g of human placenta, 100-300 g of endothelium corneum gigeriae galli, 200-300 g of herba patriniae, 100-200 g of white red peony root, 200-300 g of motherwort, 200-300 g of dandelion, 200-300 g of calcined alum, 50-100 g of borneol, 100-200 g of radix sophorae flavescentis, 100-200 g of fructus cnidii, 100-200 g of fructus kochiae, 300-400 g of dragon's blood and 100-200 g of safflower.

Description

Medicament for treating gynecological diseases
Technical Field
The invention relates to the technical field of traditional Chinese medicine treatment, in particular to a medicament for treating gynecological diseases.
Background
The female reproductive system diseases are gynecological diseases, including vulvar diseases, vaginal diseases, uterine diseases, fallopian tube diseases, ovarian diseases, etc. The gynecological diseases are common diseases and frequently encountered diseases of women. However, many people lack due knowledge of gynecological diseases, lack of health care of the body, and various bad living habits and habits, so that the physiological health of the people is gradually improved, some female diseases are entangled and cannot be cured for a long time, and great inconvenience is brought to normal life and work.
The traditional Chinese medicine is a crystal of the experience of preventing and treating diseases of Chinese nationalities for thousands of years, and is a life science with Chinese characteristics. It is rich in flavor, profound in connotation, has systematic theoretical system, abundant practical experience and obvious clinical curative effect. The traditional Chinese medicine researches a series of health preserving principles of coordinating yin and yang, complying with nature, regulating diet, taking care of living, regulating viscera, dredging channels and collaterals, regulating desire, preserving sperm, tonifying qi, regulating rest, and being suitable for movement and inertia, and the coordination and balance are the core ideas of the health preserving principles. It is the most healthy when one's body reaches "yin-yang balance", i.e. internal-external balance. The traditional Chinese medicine is a green natural therapy without side effect, and has unique insights in health preservation and unique features in treating chronic diseases.
In the process of treating gynecological diseases, light patients need to use lotion and the like to clean every day to keep sanitary and clean, but the lotion is very inconvenient to carry and use when the patients are out due to the adoption of liquid medicament lotion, and serious patients need to be hospitalized and cleaned by the aid of the lotion, so that the treatment cost is high, the recovery period of chronic diseases is long, and the patients are full of treatment pain.
Disclosure of Invention
In order to solve the technical problems, the invention provides the medicament for treating the gynecological diseases, which has the advantages of good treatment effect, convenient carrying and use, low cost, short treatment course and high cure rate.
The invention relates to a medicament for treating gynecological diseases, which is powder with the fineness of more than 95 percent and passing through a 75 mu m test sieve, and comprises the following raw materials: placenta hominis, endothelium corneum Gigeriae Galli, herba Patriniae, radix Paeoniae Rubra, herba Leonuri, herba Taraxaci, calcined Alumen, Borneolum Syntheticum, radix Sophorae Flavescentis, fructus Cnidii, Kochiae fructus, sanguis Draxonis and Carthami flos.
The invention relates to a medicament for treating gynecological diseases, which comprises the following raw materials in percentage by weight: 300-400 g of human placenta, 100-300 g of endothelium corneum gigeriae galli, 200-300 g of herba patriniae, 100-200 g of white red peony root, 200-300 g of motherwort, 200-300 g of dandelion, 200-300 g of calcined alum, 50-100 g of borneol, 100-200 g of radix sophorae flavescentis, 100-200 g of fructus cnidii, 100-200 g of fructus kochiae, 300-400 g of dragon's blood and 100-200 g of safflower.
The motherwort is dry motherwort, and fresh motherwort is cleaned, cut into sections and dried after impurities are removed.
The invention relates to a medicament for treating gynecological diseases, which is prepared by the following steps:
s1, raw material pretreatment: cleaning the surfaces of the raw materials, and cutting the raw materials into small pieces;
s2, decocting the raw materials: adding herba patriniae, white red peony root, dandelion, radix sophorae flavescentis, fructus kochiae and safflower into a decocting pot, adding water to immerse medicinal materials, soaking for 2-4 hours, decocting, and repeatedly decocting for 2-3 times;
s3, spray drying: mixing the decocted liquid, spraying powder, drying, removing water to obtain dry material powder, and pulverizing the larger part of the particles;
s4, grinding and crushing: fully drying placenta hominis, endothelium corneum Gigeriae Galli, herba Leonuri, calcined Alumen, Borneolum Syntheticum, fructus Cnidii and sanguis Draxonis, pulverizing respectively, and grinding to obtain material powder;
s5, mixing and sterilizing: and (4) uniformly mixing the material powder obtained in the S3 and the S4, sieving, and performing high-temperature sterilization treatment on the sieved material.
The high-temperature sterilization method used in S5 is a dry heat sterilization method, and the medicament is treated at 160-170 ℃ for 1-2 hours.
The medicament for treating the gynecological diseases is prepared by taking 2g of the obtained dry powder as one piece and using the powder once a day.
When the medicament for treating the gynecological diseases is used, the powder is pushed into the vagina of a patient, a protection pad is padded, and the protection pad is replaced every 2-3 hours.
Compared with the prior art, the invention has the beneficial effects that:
1. the medicament for treating the gynecological diseases uniformly divides the obtained medicament into single-use doses for storage, a user does not need to carry all medicaments when going out, only needs to carry the required doses, is convenient and sanitary to use, can discard the storage tool after use, and has simple use mode and no secondary pollution phenomenon;
2. the operation can be completed by a user at home without hospitalization, the treatment effect is good, the carrying and the use are convenient, the cost is low, the treatment course is short, the cure rate is high, the worries of the patient are solved, and the normal working life of the patient is not influenced;
3. the medicament has the main treatment effects that: diminishing inflammation, sterilizing, removing necrotic tissue, promoting granulation, removing speckle, caring skin, removing dampness, removing acne, relaxing muscles and tendons, regulating qi-flowing, promoting blood circulation, removing blood stasis, expelling pathogenic wind, dispelling cold, dredging channels and collaterals, astringing, and stopping bleeding;
4. the medicament of the invention is mainly used for treating: cervical erosion, uterine prolapse, endometrial hyperplasia, endometriosis, ovarian cyst, uterine myoma, hyperplasia of mammary glands, adenomyosis, dysmenorrhea, hyperthyroidism, cervical polyps, damaged endometrium, various vaginitis, cervicitis, endometritis, adnexitis, pelvic inflammatory disease, pelvic effusion, abnormal leucorrhea, peculiar smell, weight loss, hemorrhoids, pruritus vulvae, pruritus ani, leakage of urine, wrinkle removal, climacteric symptoms, continuous dripping, mycotic vaginitis, trichomonas vaginitis, metrorrhagia, HpA positive, sequelae caused by uterine extirpation, pain during intimate contact, cold womb, infertility caused by blockage of fallopian tube, abdominal pain, soreness and pain of waist, breast fibroma, breast pain, frigidity, dryness and relaxation, and wide application.
Detailed Description
The following examples are given to further illustrate the embodiments of the present invention. The following examples are intended to illustrate the invention but are not intended to limit the scope of the invention.
Examples
The invention relates to a medicament for treating gynecological diseases, which comprises the following raw materials: placenta hominis, endothelium corneum gigeriae galli, herba patriniae, radix paeoniae rubra, motherwort, dandelion, calcined alum, borneol, radix sophorae flavescentis, fructus cnidii, fructus kochiae, dragon's blood and safflower, wherein the addition amount of each raw material is as follows: 300-400 g of human placenta, 100-300 g of endothelium corneum gigeriae galli, 200-300 g of herba patriniae, 100-200 g of white red peony root, 200-300 g of motherwort, 200-300 g of dandelion, 200-300 g of calcined alum, 50-100 g of borneol, 100-200 g of radix sophorae flavescentis, 100-200 g of fructus cnidii, 100-200 g of fructus kochiae, 300-400 g of dragon's blood and 100-200 g of safflower.
The herba Leonuri is dried herba Leonuri, and is prepared by removing impurities from fresh herba Leonuri, cleaning rapidly, cutting into segments, and drying.
The invention relates to a medicament for treating gynecological diseases, which comprises the following steps in the preparation process:
s1, raw material pretreatment: cleaning the surfaces of the raw materials, and cutting the raw materials into small pieces;
s2, decocting the raw materials: adding herba patriniae, white red peony root, dandelion, radix sophorae flavescentis, fructus kochiae and safflower into a decocting pot, adding water to immerse medicinal materials, soaking for 2-4 hours, decocting, and repeatedly decocting for 2-3 times;
s3, spray drying: mixing the decocted liquid, spraying powder, drying, removing water to obtain dry material powder, and pulverizing the larger part of the particles;
s4, grinding and crushing: fully drying placenta hominis, endothelium corneum Gigeriae Galli, herba Leonuri, calcined Alumen, Borneolum Syntheticum, fructus Cnidii and sanguis Draxonis, pulverizing respectively, and grinding to obtain material powder;
s5, mixing and sterilizing: and (3) uniformly mixing the material powder obtained in the S3 and the S4, sieving, passing the material powder through a 75-micron test sieve, wherein the passing part is more than 95%, performing high-temperature sterilization treatment on the sieved material by adopting a dry heat sterilization method, and treating for 1-2 hours at 160-170 ℃.
Taking each 2g of the obtained dry powder as one piece, sealing and storing, using once a day, pushing the powder with single use amount into the vagina of a patient when using, and filling a protection pad, and replacing the protection pad once every 2-3 h.
The patients: the medicine is used for treating a woman in Zhouji, the woman is 46 years old, the histopathological examination is carried out on 3-22 days in 2019, the clinical diagnosis is cervical lesion, cervical biopsy is carried out, a pile of gray crushed tissues is seen by naked eyes, the total volume is 1 x 0.5cm, the pathological diagnosis is chronic cervicitis and endocervitis accompanied by local low-grade squamous intraepithelial lesion, the medicine is used for treating the chronic cervicitis and the endocervitis, the medicine is used once every time and once every day, the medicine is continuously used, the examination is carried out again on 6-20 days in 2019, cervical secretion is collected for examination, and the following numerical values are obtained:
serial number Name of item Results Unit of Reference range
1 HPV type 16 2, llE +04 (Positive) copics/ml <l.OE+04
2 HPV type 56 <l.OE+04 copics/ml <l.OE+04
3 HPV type 18 <l.OE+04 copics/ml <l.OE+04
4 HPV type 45 <l.OE+04 copics/ml <l.OE+04
5 HPV type 35 <l.OE+04 copics/ml <l.OE+04
6 HPV type 59 <l.OE+04 copics/ml <l.OE+04
7 HPV type 39 <l.OE+04 copics/ml <l.OE+04
8 HPV type 51 <l.OE+04 copics/ml <l.OE+04
9 HPV type 58 <l.OE+04 copics/ml <l.OE+04
10 HPV type 52 <l.OE+04 copics/ml <l.OE+04
11 HPV type 31 <l.OE+04 copics/ml <l.OE+04
12 HPV type 33 <l.OE+04 copics/ml <l.OE+04
13 HPV 66 type <l.OE+04 copics/ml <l.OE+04
14 HPV type 68 <l.OE+04 copics/ml <l.OE+04
15 HPV type 82 <l.OE+04 copics/ml <l.OE+04
After the detection of the patient is finished, the medicine is continuously used after the patient returns home, one medicine is used each time, the medicine is used once a day and is continuously used, the cervical/vaginal cytology detection is carried out again in 8 months and 10 days in 2019, and the diagnosis report is obtained as follows:
specimen satisfaction degree: satisfying;
degree of inflammation: mild;
cell amount: is more than 40 percent;
neck tube cells: comprises the following steps of;
metaplastic cells: comprises the following steps of;
pathogenic microorganisms:
prompting actinomycete infection: none;
flora shift suggests: none;
mould infection suggests: none;
trichomonas infection prompting: none;
HPV infection suggests: none;
the indication of rash infection: none;
squamous epithelial cell analysis: no abnormality is found;
glandular epithelial cell analysis: no abnormality is found;
TBS diagnosis: not found in the above intradermal diseased cells or malignant cells;
and (4) adding opinions: periodic review is recommended.
After the detection of the patient is finished, the medicine is continuously used after the patient returns home, one medicine is used each time, the medicine is used once a day and is continuously used, the examination is carried out again in 2019, 11 and 15 days, cervical secretions are collected for examination, and the following numerical values are obtained:
Figure BDA0002354426250000061
Figure BDA0002354426250000071
the above description is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, several modifications and variations can be made without departing from the technical principle of the present invention, and these modifications and variations should also be regarded as the protection scope of the present invention.

Claims (7)

1. A medicament for treating gynaecological disorders, characterized in that it is a powder with a fineness of > 95% passing through a 75 μm sieve test, comprising the following raw materials: placenta hominis, endothelium corneum Gigeriae Galli, herba Patriniae, radix Paeoniae Rubra, herba Leonuri, herba Taraxaci, calcined Alumen, Borneolum Syntheticum, radix Sophorae Flavescentis, fructus Cnidii, Kochiae fructus, sanguis Draxonis and Carthami flos.
2. The medicament for treating gynecological diseases according to claim 1, wherein the addition amount of each raw material is: 300-400 g of human placenta, 100-300 g of endothelium corneum gigeriae galli, 200-300 g of herba patriniae, 100-200 g of white red peony root, 200-300 g of motherwort, 200-300 g of dandelion, 200-300 g of calcined alum, 50-100 g of borneol, 100-200 g of radix sophorae flavescentis, 100-200 g of fructus cnidii, 100-200 g of fructus kochiae, 300-400 g of dragon's blood and 100-200 g of safflower.
3. The medicament for treating gynecological diseases according to any one of claims 1 to 2, wherein the motherwort is dry motherwort, which is prepared by removing impurities from fresh motherwort, washing the cleaned motherwort quickly, cutting the cleaned motherwort into segments and drying the segments.
4. A medicament as claimed in any one of claims 1 to 2, for the treatment of gynaecological disorders, prepared by a method comprising the steps of:
s1, raw material pretreatment: cleaning the surfaces of the raw materials, and cutting the raw materials into small pieces;
s2, decocting the raw materials: adding herba patriniae, white red peony root, dandelion, radix sophorae flavescentis, fructus kochiae and safflower into a decocting pot, adding water to immerse medicinal materials, soaking for 2-4 hours, decocting, and repeatedly decocting for 2-3 times;
s3, spray drying: mixing the decocted liquid, spraying powder, drying, removing water to obtain dry material powder, and pulverizing the larger part of the particles;
s4, grinding and crushing: fully drying placenta hominis, endothelium corneum Gigeriae Galli, herba Leonuri, calcined Alumen, Borneolum Syntheticum, fructus Cnidii and sanguis Draxonis, pulverizing respectively, and grinding to obtain material powder;
s5, mixing and sterilizing: and (4) uniformly mixing the material powder obtained in the S3 and the S4, sieving, and performing high-temperature sterilization treatment on the sieved material.
5. The pharmaceutical preparation according to claim 4, wherein the high temperature sterilization treatment used in S5 is dry heat sterilization, and the treatment is performed at 160-170 ℃ for 1-2 h.
6. The agent for treating gynecological diseases according to claim 4, wherein the obtained dry powder is used once a day as one tablet per 2 g.
7. A medicament for the treatment of gynaecological disorders according to claims 1 to 6, wherein in use the powder is pushed into the patient's vagina and padded with a pad, the pad being changed every 2-3 hours.
CN202010003734.0A 2020-01-03 2020-01-03 Medicament for treating gynecological diseases Pending CN110946937A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010003734.0A CN110946937A (en) 2020-01-03 2020-01-03 Medicament for treating gynecological diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010003734.0A CN110946937A (en) 2020-01-03 2020-01-03 Medicament for treating gynecological diseases

Publications (1)

Publication Number Publication Date
CN110946937A true CN110946937A (en) 2020-04-03

Family

ID=69985484

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010003734.0A Pending CN110946937A (en) 2020-01-03 2020-01-03 Medicament for treating gynecological diseases

Country Status (1)

Country Link
CN (1) CN110946937A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102085266A (en) * 2011-01-24 2011-06-08 通化金马药业集团股份有限公司 Anti-erosive suppository for treating gynecological infection and preparation method thereof
CN104116981A (en) * 2014-07-29 2014-10-29 李献国 Traditional Chinese medicine composition for treating gynecopathy and preparation method of traditional Chinese medicine composition as well as medical panty liner applying traditional Chinese medicine composition and preparation method of medical panty liner
CN105232977A (en) * 2015-10-20 2016-01-13 丁红梅 External use medicine for treating gynecologic inflammation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102085266A (en) * 2011-01-24 2011-06-08 通化金马药业集团股份有限公司 Anti-erosive suppository for treating gynecological infection and preparation method thereof
CN104116981A (en) * 2014-07-29 2014-10-29 李献国 Traditional Chinese medicine composition for treating gynecopathy and preparation method of traditional Chinese medicine composition as well as medical panty liner applying traditional Chinese medicine composition and preparation method of medical panty liner
CN105232977A (en) * 2015-10-20 2016-01-13 丁红梅 External use medicine for treating gynecologic inflammation

Similar Documents

Publication Publication Date Title
CN103007124A (en) Chinese medicine preparation for treating gynecologic inflammation
CN103638511A (en) Postpartum stasis removing particles
CN103349766B (en) Pharmaceutical composition for endless postpartum lochia
CN102133376A (en) Formula of Chinese medicinal herb for conditioning myoma of uterus
CN101461916B (en) External-use Chinese medicinal composition for treating gynecopathy and method for formulating the same
CN101244241A (en) Cunt shrinking and maintaining agent for gynaecologic treatment
CN102846858A (en) Antibacterial pharmaceutical composition
CN112022916A (en) Traditional Chinese medicine composition and preparation for treating postpartum body pain and preparation method and application thereof
CN103505599A (en) Traditional Chinese medicine composition for treating breast pain
CN103212047A (en) Traditional Chinese medicine composition for treating hysteromyoma and ovarian cysts
CN110946937A (en) Medicament for treating gynecological diseases
CN104474414B (en) A kind of medicine for treating gynaecological imflammation and preparation method thereof
CN102940821A (en) Traditional Chinese medicine for treating morbid leucorrhea of gynaecology
CN103550708B (en) Chinese herbal compound for treating dysmenorrheal
CN105055831A (en) Traditional Chinese medicine for treating leukorrhagia of women and preparation method thereof
CN1994366B (en) Chinese medicinal formulation for treating gynecological disease and preparation process thereof
CN104257813B (en) A kind of Chinese medicine composition of QI and blood regulating and preparation method thereof
CN102389557B (en) Chinese medicinal composition and Chinese medicinal ball for treating uterine cancer and application thereof
CN108969697B (en) Medicine formula for treating leukoplakia vulvae and preparation process thereof
CN103041017B (en) Traditional Chinese medicine preparation for treating functional uterine bleeding and preparation method thereof
CN1410112A (en) Fuyuan plaster for promoting blood circulation
CN101401905B (en) Chinese medicinal composition for treating aplastic anemia
CN102824611B (en) Traditional Chinese medicine for treating menstrual disorder
CN106266986A (en) A kind of Chinese medicine composition for treating hysteromyoma
CN105596620A (en) Chinese herbal medicine for treating miscellaneous gynecological diseases

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20200403

RJ01 Rejection of invention patent application after publication